Highland Capital Management (Texas)’s Aerie Pharmaceuticals AERI Stock Holding History

Highland Capital Management (Texas)’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$23M	Buy	778,791 +254,700	+49%	+$9.81M	1.35%	14
2019 Q1	$24.9M	Buy	524,091 +176,400	+51%	+$7.76M	1.55%	11
2018 Q4	$12.6M	Buy	347,691 +166,700	+92%	+$7.82M	0.96%	15
2018 Q3	$11.1M	Buy	180,991 +72,991	+68%	+$4.69M	0.61%	38
2018 Q2	$7.3M	Sell	108,000 -55,300	-34%	-$3.09M	0.41%	62
2018 Q1	$8.86M	Buy	+163,300	New	+$9.13M	0.46%	57
2017 Q4	–	Sell	-35,000	Closed	-$1.7M	–	354
2017 Q3	$1.7M	Buy	+35,000	New	+$1.91M	0.08%	161
2017 Q2	–	Sell	-46,000	Closed	-$2.09M	–	350
2017 Q1	$2.09M	Buy	+46,000	New	+$2.05M	0.11%	152

Other funds holding AERI

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Highland Capital Management (Texas)'s AERI Position: Q2 2019 in Review

Highland Capital Management (Texas) increased its Aerie Pharmaceuticals (AERI) stake by 49% in Q2 2019, buying an estimated $9.81M and bringing the position to 778,791 shares worth $23M. The position accounts for 1.35% of the portfolio, ranked #14.

Highland Capital Management (Texas) first reported a position in AERI in Q1 2017 and has held it in 8 quarters since. The position peaked at $24.9M in Q1 2019. 167 funds tracked by Wall St. Rank hold AERI as of Q2 2019.

Highland Capital Management (Texas) held 778,791 shares of Aerie Pharmaceuticals worth $23M as of Q2 2019.
Highland Capital Management (Texas) bought 254,700 Aerie Pharmaceuticals shares in Q2 2019, an estimated $9.81M.
Aerie Pharmaceuticals made up 1.35% of Highland Capital Management (Texas)'s portfolio in Q2 2019, its #14 holding.
Highland Capital Management (Texas) first reported a position in Aerie Pharmaceuticals in Q1 2017 and has held it in 8 quarters since.
Highland Capital Management (Texas)'s Aerie Pharmaceuticals position peaked at $24.9M in Q1 2019.
167 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q2 2019.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2019, filed 14 Aug 2019.